본문으로 건너뛰기
← 뒤로

Multi-omics analysis reveals features improving outcomes and immunotherapy resistance in MSS colorectal cancer.

1/5 보강
iScience 📖 저널 OA 100% 2023: 4/4 OA 2024: 21/21 OA 2025: 69/69 OA 2026: 112/112 OA 2023~2026 2026 Vol.29(3) p. 114817
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
환자: high immune infiltration
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Mechanistically, CADM1 was identified as a key molecule associated with MLDMPIS. Functional analyses revealed that CADM1 promotes tumor stemness, thereby enhancing proliferation, invasion, and metastasis in MSS CRC.

Xu H, Zuo A, Ba Y, Liu S, Han X, Liu Z, Zhu H

📝 환자 설명용 한 줄

In contrast to the MSI-H subtype, most microsatellite-stable (MSS) colorectal cancer (CRC) patients exhibit poor prognosis and limited responsiveness to immunotherapy, highlighting the urgent need for

이 논문을 인용하기

↓ .bib ↓ .ris
APA Xu H, Zuo A, et al. (2026). Multi-omics analysis reveals features improving outcomes and immunotherapy resistance in MSS colorectal cancer.. iScience, 29(3), 114817. https://doi.org/10.1016/j.isci.2026.114817
MLA Xu H, et al.. "Multi-omics analysis reveals features improving outcomes and immunotherapy resistance in MSS colorectal cancer.." iScience, vol. 29, no. 3, 2026, pp. 114817.
PMID 41852723 ↗

Abstract

In contrast to the MSI-H subtype, most microsatellite-stable (MSS) colorectal cancer (CRC) patients exhibit poor prognosis and limited responsiveness to immunotherapy, highlighting the urgent need for robust biomarkers to stratify prognosis and predict immunotherapy responsiveness. Here, 68 single-cell and 3,767 bulk transcriptome samples were integrated to identify and validate MSS patients with high immune infiltration. Multidimensional, prognosis-related, and immunological features specific to MSS CRC were characterized at cellular and genetic levels. To reduce algorithm selection bias, 93 artificial intelligence algorithms were applied to construct a machine learning-derived MSS prognostic-immune signature (MLDMPIS). MLDMPIS demonstrated robust prognostic and immunotherapy response prediction performance in 1,323 MSS patients and six independent immunotherapy cohorts, outperforming clinical indicators, published prognostic signatures, and immune response models. Mechanistically, CADM1 was identified as a key molecule associated with MLDMPIS. Functional analyses revealed that CADM1 promotes tumor stemness, thereby enhancing proliferation, invasion, and metastasis in MSS CRC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기